Prothena Corp. Plc

( )
PRTA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
GILDGilead Sciences, Inc. -3.94%74.671.0%$1808.50m
AMGNAmgen, Inc. -1.32%208.781.3%$898.33m
REGNRegeneron Pharmaceuticals, Inc. -0.55%501.512.6%$832.58m
BIIBBiogen, Inc. -3.27%301.211.5%$768.55m
VRTXVertex Pharmaceuticals, Inc. -2.99%247.671.9%$644.24m
MRNAModerna, Inc. -7.56%32.020.0%$518.77m
ILMNIllumina, Inc. 0.95%280.643.5%$494.32m
ALXNAlexion Pharmaceuticals, Inc. -1.24%94.722.0%$299.75m
AAgilent Technologies, Inc. -0.46%74.021.6%$226.92m
INCYIncyte Corp. 1.82%86.662.5%$218.22m
EXASEXACT Sciences Corp. 0.53%62.6021.0%$178.66m
SGENSeattle Genetics, Inc. -2.09%121.876.1%$164.60m
BMRNBioMarin Pharmaceutical, Inc. -3.55%79.834.3%$153.92m
IMMUImmunomedics, Inc. 0.69%18.9111.9%$120.80m
NVAXNovavax, Inc. -7.45%14.90114.7%$113.95m

Company Profile

Prothena Corp. Plc is a clinical-stage neuroscience company. It focuses on the discovery and development of novel therapies to change the course of devastating diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.